# Lemon (Citrus limon)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/lemon-citrus-limon
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 1 / 10
**Category:** Middle Eastern
**Also Known As:** Citrus limon, Limon, Nimbu, Hamad, Citron de Malabar, Limone

## Overview

Lemon contains flavonoids (eriocitrin at up to 3.35 mg/g in peel, hesperidin at 14.1 mg/100 mL juice), limonoids (150–300 ppm in juice), vitamin C (53 mg/100 g), and terpenoids (limonene up to 48.9% of essential oil) that exert [antioxidant](/ingredients/condition/antioxidant), [anti-inflammatory](/ingredients/condition/inflammation), and apoptotic effects through free-radical scavenging, NF-κB suppression, and caspase-3 activation. In vitro, lemon peel extract exhibits DPPH radical-scavenging activity approximately 20-fold more potent than flesh extract (IC50 434.50 μg/mL vs. 1,126,990 μg/mL), and limonoids induce pancreatic cancer cell apoptosis with IC50 values below 50 μM at 72 hours.

## Health Benefits

- **[Antioxidant Protection](/ingredients/condition/antioxidant)**: Flavonoids and phenolic acids in lemon zest donate electrons and hydrogen atoms to neutralize DPPH radicals, with peel extract achieving an IC50 of 434.50 μg/mL—approximately 20 times more potent than flesh extract—while vitamin C (53 mg/100 g, 88% DV) contributes aqueous-phase antioxidant capacity.
- **[Anti-Inflammatory](/ingredients/condition/inflammation) Action**: Pectin-derived oligosaccharides and limonoids downregulate pro-inflammatory mediators TNF-α, IL-6, and NF-κB in macrophages, potentially reducing chronic low-grade inflammation implicated in cardiovascular and metabolic disease.
- **Anticancer Potential**: Limonoids including limonin and nomilin induce apoptosis in pancreatic cancer cell lines at IC50 values below 50 μM via caspase-3 cleavage, [mitochondrial](/ingredients/condition/energy) membrane depolarization, Bax/Bcl-2 ratio elevation, p21 induction, and downregulation of Cox-2 and IL-6.
- **Diabetes Support**: Turkish herbalism traditionally employs lemon preparations for glycemic regulation; flavonoids such as eriocitrin and hesperidin are hypothesized to inhibit α-glucosidase and reduce postprandial glucose, though robust human clinical trial data remain limited.
- **[Cardiovascular Health](/ingredients/condition/heart-health)**: Hesperidin (14.1 mg/100 mL juice) and pectin oligosaccharides modulate NF-κB and IL-10 pathways in macrophage foam cells, suggesting anti-atherosclerotic activity that may complement dietary approaches to lipid management.
- **[Neuroprotective Effect](/ingredients/condition/cognitive)s**: Essential oil constituents limonene and linalool inhibit acetylcholinesterase activity and reduce neuronal burst frequency in rat cortical networks in vitro, indicating potential relevance to cognitive and neurodegenerative conditions.
- **[Antimicrobial](/ingredients/condition/immune-support) Activity**: Ethanolic flesh extract demonstrates potent antibacterial activity against selected pathogen strains in disc-diffusion assays, attributable to the synergistic action of citric acid, flavonoids, alkaloids, and terpenoid volatiles present across peel, flesh, and essential oil fractions.

## Mechanism of Action

Lemon flavonoids—principally eriocitrin, hesperidin, and luteolin 7-O-glucoside—donate hydrogen atoms or electrons to quench [reactive oxygen species](/ingredients/condition/antioxidant) and chelate transition metal ions, disrupting Fenton-type radical chain reactions; peel phenolics including p-coumaric and gallic acid contribute additional electron-transfer capacity quantified via ferric-reducing antioxidant power assays. Limonoids (limonin, nomilin, limonexic acid) trigger intrinsic apoptosis in cancer cell lines by reducing [mitochondrial](/ingredients/condition/energy) membrane potential, upregulating the pro-apoptotic protein Bax relative to anti-apoptotic Bcl-2, activating caspase-3 cleavage, and inducing the cyclin-dependent kinase inhibitor p21, while simultaneously suppressing the inflammatory transcription factor NF-κB, Cox-2 protein expression, and IL-6 secretion. Pectin-derived oligosaccharides bind toll-like receptors and galectins on macrophage surfaces, attenuating downstream NF-κB nuclear translocation and rebalancing the TNF-α/IL-10 cytokine ratio toward an [anti-inflammatory](/ingredients/condition/inflammation) phenotype relevant to atherosclerotic plaque stability. The essential oil monoterpene limonene and the monoterpenol linalool competitively inhibit [acetylcholine](/ingredients/condition/cognitive)sterase at the enzyme's active site and modulate GABA-A receptor activity, explaining observed reductions in cortical neuronal burst frequency in rat ex vivo network models.

## Clinical Summary

No completed human RCTs with quantified primary endpoints, effect sizes, or confidence intervals have been identified specifically for standardized Citrus limon extracts as pharmaceutical or nutraceutical interventions. The strongest mechanistic data come from cell-based models: limonoids achieve sub-50 μM IC50 apoptotic effects in pancreatic cancer lines, and peel flavonoids demonstrate 20-fold superior DPPH scavenging relative to flesh fractions. Observational and ethnopharmacological data support glycemic and [anti-inflammatory](/ingredients/condition/inflammation) traditional uses in Turkish and Mediterranean populations, but dose–response relationships, pharmacokinetics, and safety margins in human subjects have not been formally characterized. Until well-designed Phase II or Phase III clinical trials are conducted with standardized lemon-derived preparations, therapeutic claims must be regarded as hypothesis-generating rather than evidence-confirmed.

## Nutritional Profile

Per 100 g raw lemon juice: approximately 22 kcal, 6.9 g carbohydrates (2.5 g sugars, 0.3 g fiber), 0.35 g protein, 0.24 g fat. Micronutrients include vitamin C 53 mg (88% DV), folate 11 μg (3% DV), potassium 138 mg (3% DV), calcium 26 mg, and vitamin B6 0.080 mg. Phytochemicals per 100 mL juice: hesperidin 14.1 mg, eriocitrin 16.7 mg, limonoids 150–300 ppm, lutein 30.51–31.65 μg, β-cryptoxanthin 17.94–20.88 μg, and limonene (predominantly in oil phase). Peel is substantially richer: eriocitrin up to 3.35 mg/g, naringin 0.11 mg/g, and essential oil 1–4% by weight. Carotenoid bioavailability is higher in cloudy than clarified juice, and flavonoid absorption is enhanced by the gut microbiota-mediated hydrolysis of glycoside bonds to yield aglycone forms.

## Dosage & Preparation

- **Fresh Juice**: 30–60 mL (approximately 2–4 tablespoons) diluted in water, consumed before meals in Turkish folk practice for glycemic support; provides roughly 8–30 mg hesperidin and 150–300 ppm limonoids per serving.
- **Ethanolic Peel Extract (Standardized)**: No universally established clinical dose; research preparations use 50–70% ethanol extracts standardized to ≥1% eriocitrin or total flavonoids; exploratory in vitro-equivalent doses suggest 200–500 mg extract per day in preclinical rationale extrapolations.
- **Essential Oil (Cold-Pressed)**: Used aromatically or in food flavoring at 1–5 drops (approximately 50–250 mg); not recommended for internal therapeutic use without dilution due to concentrated terpenoid content.
- **Cloudy Lemon Juice Concentrate**: Preferred over clarified juice for carotenoid retention (lutein 30.51–31.65 μg/100 mL); consumed as 100–200 mL daily in beverage form.
- **Whole Dried Peel (Zest) Powder**: 1–3 g/day in capsule or tea form provides concentrated eriocitrin (up to 3.35 mg/g) and phenolic acids; no standardized pharmaceutical-grade product currently approved.
- **Timing Note**: Consumption with meals may moderate postprandial glycemic response via α-glucosidase inhibition; vitamin C absorption is enhanced when taken alongside iron-containing foods.

## Safety & Drug Interactions

At typical dietary and culinary intake levels, Citrus limon is well tolerated; undiluted lemon juice is acidic (pH ~2–3) and can erode dental enamel with chronic direct contact or exacerbate gastroesophageal reflux disease (GERD) in susceptible individuals. High-dose flavonoid or limonoid extracts demonstrated dose-dependent in vitro cytotoxicity on the B95-8 cell line, but human toxicity thresholds at supplemental doses have not been established in clinical studies. Citrus flavonoids, particularly naringin and hesperidin at pharmacological doses, may inhibit CYP3A4 and P-glycoprotein drug transporters, potentially elevating plasma concentrations of statins, calcium channel blockers, immunosuppressants (e.g., cyclosporine), and certain antihistamines—a mechanism better characterized for grapefruit but relevant across Citrus species. Pregnant and lactating individuals may consume lemon in normal food quantities without known risk, but concentrated standardized extracts have not been assessed for reproductive safety; caution is advised at doses substantially exceeding typical dietary intake.

## Scientific Research

The current evidence base for Citrus limon is predominantly preclinical, consisting of in vitro cell-culture experiments and phytochemical profiling studies with no published large-scale randomized controlled trials (RCTs) specifically on lemon extracts as therapeutic agents. DPPH radical-scavenging, MTT cytotoxicity, and plasmid DNA protection assays have quantified [antioxidant](/ingredients/condition/antioxidant) and anticancer activity of peel and flesh extracts, yielding reproducible IC50 values, but these models do not translate directly to human bioavailability or clinical outcomes. Limonoid-mediated apoptosis has been demonstrated in pancreatic cancer cell lines (IC50 <50 μM at 72 h) using caspase activity assays and flow cytometry, and anti-neuronal-burst activity has been observed in rat cortical networks, but both findings await in vivo validation. Traditional use in Turkish and broader Middle Eastern herbalism for diabetes and [anti-inflammatory](/ingredients/condition/inflammation) indications is documented ethnobotanically but has not been substantiated by interventional human trials with defined endpoints, making the overall evidence level preliminary to moderate.

## Historical & Cultural Context

Lemon was cultivated in Persia and the Arab world by at least the 10th century CE and was documented by Arab physicians including Ibn Sina (Avicenna) in the Canon of Medicine (circa 1025 CE) as a treatment for liver complaints, fevers, and [cardiovascular](/ingredients/condition/heart-health) conditions. In Ottoman and Turkish herbalism, lemon juice and peel decoctions were traditionally prescribed for diabetes management, digestive disorders, and as a febrifuge, a use that persists in contemporary Turkish folk medicine. In Ayurvedic practice, lemon (nimbu) is classified as having sharp, sour, and hot properties, used to stimulate digestive fire (agni) and treat scurvy, anemia, and rheumatism. European explorers and naval physicians by the 18th century recognized lemon's anti-scorbutic properties, leading to mandatory lemon juice rations for British Royal Navy sailors—a practice that effectively eradicated scurvy on long voyages and predated the formal discovery of vitamin C by over a century.

## Synergistic Combinations

Lemon flavonoids (eriocitrin, hesperidin) and vitamin C demonstrate complementary antioxidant synergy: vitamin C operates in aqueous phases quenching superoxide and hydroxyl radicals, while lipophilic flavonoids protect membrane-associated lipids, together providing broader [oxidative stress](/ingredients/condition/antioxidant) coverage than either compound alone. Combining lemon peel extract with green tea catechins (EGCG) may enhance NF-κB suppression and apoptotic signaling through additive inhibition of upstream kinases IKKβ and PI3K, a pairing observed in polyphenol co-treatment models. In traditional Ayurvedic and Middle Eastern formulations, lemon is frequently combined with ginger (Zingiber officinale), whose gingerols independently inhibit Cox-2 and TNF-α, potentially amplifying the [anti-inflammatory](/ingredients/condition/inflammation) effects of lemon's pectin oligosaccharides and limonoids through complementary pathway targeting.

## Frequently Asked Questions

### What are the main bioactive compounds in lemon and what do they do?

Lemon's primary bioactives include flavonoids (eriocitrin up to 3.35 mg/g in peel, hesperidin 14.1 mg/100 mL juice), limonoids (150–300 ppm in juice), vitamin C (53 mg/100 g), and essential oil terpenoids (limonene up to 48.9%). These compounds collectively scavenge free radicals, suppress the inflammatory transcription factor NF-κB, inhibit acetylcholinesterase, and trigger apoptosis in cancer cell lines via caspase-3 activation and Bax/Bcl-2 modulation.

### Can lemon help with blood sugar and diabetes management?

In Turkish herbalism, lemon juice and peel preparations have long been used for diabetes support, and flavonoids such as eriocitrin and hesperidin are hypothesized to inhibit α-glucosidase enzymes that break down dietary carbohydrates, thereby blunting postprandial glucose spikes. However, no large human RCTs have confirmed this effect for standardized lemon extracts, so current evidence is based on traditional use and preliminary in vitro data, and lemon should not replace prescribed antidiabetic medications.

### Is the lemon peel more beneficial than the juice?

Yes, in terms of flavonoid and phenolic density: lemon peel contains eriocitrin at up to 3.35 mg/g and exhibits DPPH radical-scavenging activity roughly 20 times more potent than flesh extract (IC50 434.50 μg/mL vs. 1,126,990 μg/mL). Juice, however, provides better carotenoid content (lutein ~31 μg/100 mL in cloudy form) and higher volumes of hesperidin, making whole-fruit consumption or cloudy juice preferable to clarified juice for overall phytochemical intake.

### Are there any drug interactions or safety concerns with lemon supplements?

Concentrated lemon flavonoid extracts may inhibit the liver enzyme CYP3A4 and the drug efflux transporter P-glycoprotein, potentially raising blood levels of statins, calcium channel blockers, cyclosporine, and certain antihistamines—a risk better documented for grapefruit but relevant to high-dose Citrus preparations generally. At normal dietary intake (juice, zest in cooking), lemon is safe for most adults; however, its low pH (approximately 2–3) can erode dental enamel with chronic undiluted use and may worsen GERD symptoms.

### What does the clinical research say about lemon's anticancer properties?

In vitro studies show that lemon limonoids (limonin, nomilin, limonexic acid) inhibit pancreatic cancer cell viability with IC50 values below 50 μM at 72 hours by activating caspase-3, reducing mitochondrial membrane potential, and suppressing NF-κB and Cox-2. These are cell-culture findings only; no human clinical trials have tested lemon-derived limonoids as cancer therapeutics, and these results should not be interpreted as evidence that consuming lemon prevents or treats cancer in people.

### What is the best form of lemon supplement—fresh juice, powder, extract, or peel supplement?

Lemon peel extract is typically the most potent form due to its concentration of flavonoids and phenolic acids, with studies showing peel extract achieving significantly higher antioxidant capacity (IC50 of 434.50 μg/mL) compared to flesh extract. Standardized lemon extracts offer consistent bioactive compound levels, while fresh juice provides vitamin C but loses many beneficial compounds during processing; powder forms fall between these options depending on whether the whole fruit or just peel is used. For maximum antioxidant benefit, peel-based supplements or whole-fruit extracts are preferable to juice alone.

### How much lemon should I consume daily to get meaningful health benefits from supplementation?

Clinical studies on lemon supplementation typically use 500–1,000 mg daily of standardized extract or the equivalent of 1–2 whole lemons' worth of bioactive compounds, though optimal dosing varies by health goal and product potency. Vitamin C content alone (approximately 53 mg per 100g lemon flesh) means consuming one medium lemon provides roughly 88% of the daily value, but achieving meaningful anti-inflammatory or additional antioxidant benefits typically requires concentrated extracts. Individual factors like body weight, existing antioxidant status, and health condition should guide dosing, making consultation with a healthcare provider advisable for supplemental use.

### Who benefits most from lemon supplementation, and are certain populations better candidates than others?

Individuals with elevated inflammatory markers, pre-diabetic glucose control concerns, or those seeking enhanced antioxidant protection may benefit most from lemon supplementation, particularly those with limited intake of citrus fruits. People with chronic diseases involving oxidative stress—such as metabolic syndrome or cardiovascular disease—represent ideal candidates, as do those taking medications that deplete antioxidant status. Conversely, individuals already consuming high amounts of citrus or those with GERD or citric acid sensitivity should approach supplementation cautiously, and pregnant or nursing women should consult healthcare providers given limited safety data in these populations.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*